November 25, 2008; 71 (22) Views and Reviews
Excessive acute migraine medication use and migraine progression
Marcelo E. Bigal, Richard B. Lipton
First published November 24, 2008, DOI: https://doi.org/10.1212/01.wnl.0000335946.53860.1d
Excessive acute migraine medication use and migraine progression
Marcelo E. Bigal, Richard B. Lipton
Neurology Nov 2008, 71 (22) 1821-1828; DOI: 10.1212/01.wnl.0000335946.53860.1d
Citation Manager Formats
Make Comment
See Comments

Article Information
vol. 71 no. 22 1821-1828
PubMed:
Print ISSN:
Online ISSN:
History:
- First Published November 24, 2008.
Copyright & Usage:
© 2008
Author Disclosures
- Marcelo E. Bigal, MD, PhD and
- Richard B. Lipton, MD
- Marcelo E. Bigal, MD, PhD and
- Richard B. Lipton, MD
- From Merck Research Laboratories (M.E.B.), Whitehouse Station, NJ; Departments of Neurology (M.E.B., R.B.L.) and Epidemiology and Population Health (R.B.L.), Albert Einstein College of Medicine, Bronx; and The Montefiore Headache Center (R.B.L.), Bronx, NY.
- Address correspondence and reprint requests to Dr. Marcelo E. Bigal, 1 Merck Drive, Whitehouse Station, NJ 08889 marcelo_bigal{at}merck.com
Article usage
Cited By...
Letters: Rapid online correspondence
- Excessive acute migraine medication use and migraine progression
- Nitin K. Sethi, MD, New York Presbyterian Hospital, Weill Cornell Medical Center, 525 East 68th Street, New York, NY 10021sethinitinmd@hotmail.com
Submitted February 06, 2009
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
- Article
- Abstract
- NOMENCLATURE FOR CDH, SMO, TRANSFORMED, AND CHRONIC MIGRAINE
- CM AND SMO AS PUBLIC HEALTH PROBLEMS
- CM AND SMO ARE ASSOCIATED
- EVIDENCE FROM CLINIC-BASED STUDIES
- POPULATION-BASED STUDIES
- CROSS-SECTIONAL ANALYSES ON PATTERNS OF USE OF MEDICATION IN THE US POPULATION
- CASE-CONTROL STUDIES
- LONGITUDINAL STUDIES
- DOSE RESPONSE EFFECTS
- CLINICAL IMPLICATIONS AND CONCLUSIONS
- Footnotes
- REFERENCES
- Figures & Data
- Info & Disclosures
Advertisement
Hemiplegic Migraine Associated With PRRT2 Variations A Clinical and Genetic Study
Dr. Robert Shapiro and Dr. Amynah Pradhan